Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Influencing drug molecule and product design using chemical stability knowledge.

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Poster
  • By: OTTOSSON, Jenny (AstraZeneca, Pharmaceutical Sciences, Mölndal, Sweden)
  • Co-author(s): Jenny Ottosson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
    Carolyn Stevenson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
    Karin Carlsson: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
    Angela Ku: Pharmaceutical Sciences, AstraZeneca, Mölndal, Sweden
  • Abstract:

    Backgrounds

    Using experimental data and knowledge of drug molecule characteristics can influence product design, identify risks and any needed mitigation. 

    Aims

    In the very early stages of drug development however it can sometimes be hard to see where and how to influence the molecule design based on potential drug product stability concerns, which

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses